Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells

BACKGROUND: Histone deacetylase (HDAC) inhibitors are widely used in clinical investigation as novel drug targets. For example, panobinostat and vorinostat have been used to treat patients with melanoma. However, HDAC inhibitors are small-molecule compounds without a specific target, and their mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaqi, Gu, Jianying, Feng, Zihao, Yang, Yanhong, Zhu, Ningwen, Lu, Weiyue, Qi, Fazhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706654/
https://www.ncbi.nlm.nih.gov/pubmed/26747087
http://dx.doi.org/10.1186/s12967-015-0753-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706654/
https://www.ncbi.nlm.nih.gov/pubmed/26747087
http://dx.doi.org/10.1186/s12967-015-0753-0

Ejemplares similares